Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 194

Similar articles for PubMed (Select 18694965)

1.

A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.

Yamanaka H, Hoyt T, Yang X, Golden S, Bosio CM, Crist K, Becker T, Maddaloni M, Pascual DW.

Infect Immun. 2008 Oct;76(10):4564-73. doi: 10.1128/IAI.00581-08. Epub 2008 Aug 11.

2.

Plague vaccines: current developments and future perspectives.

Feodorova VA, Motin VL.

Emerg Microbes Infect. 2012 Nov;1(11):e36. doi: 10.1038/emi.2012.34. Epub 2012 Nov 7. Review.

3.

Correction: Yersinia pestis Activates Both IL-1β and IL-1 Receptor Antagonist to Modulate Lung Inflammation during Pneumonic Plague.

PLOS Pathogens Staff.

PLoS Pathog. 2015 May 13;11(5):e1004921. doi: 10.1371/journal.ppat.1004921. eCollection 2015 May. No abstract available.

4.

Selective Protective Potency of Yersinia pestis ΔnlpD Mutants.

Dentovskaya SV, Ivanov SA, Kopylov PKh, Shaikhutdinova RZ, Platonov ME, Kombarova TI, Gapel'chenkova TV, Balakhonov SV, Anisimov AP.

Acta Naturae. 2015 Jan-Mar;7(1):102-8.

5.

Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens.

Fan Y, Sahdev P, Ochyl LJ, J Akerberg J, Moon JJ.

J Control Release. 2015 Jun 28;208:121-9. doi: 10.1016/j.jconrel.2015.04.010. Epub 2015 Apr 11.

PMID:
25869965
6.

[Effect of immune modulation on immunogenic and protective activity of a live plague vaccine].

Karal'nik BV, Ponomareva TS, Deriabin PN, Denisova TG, Mel'nikova NN, Tugambaev TI, Atshabar BB, Zakarian SB.

Zh Mikrobiol Epidemiol Immunobiol. 2014 Nov-Dec;(6):108-12. Russian.

PMID:
25816525
7.

Primary case of human pneumonic plague occurring in a Himalayan marmot natural focus area Gansu Province, China.

Ge P, Xi J, Ding J, Jin F, Zhang H, Guo L, Zhang J, Li J, Gan Z, Wu B, Liang J, Wang X, Wang X.

Int J Infect Dis. 2015 Apr;33:67-70. doi: 10.1016/j.ijid.2014.12.044. Epub 2014 Dec 30.

8.

HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.

Batra L, Verma SK, Nagar DP, Saxena N, Pathak P, Pant SC, Tuteja U.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3322. doi: 10.1371/journal.pntd.0003322. eCollection 2014 Dec.

9.

A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.

Galen JE, Wang JY, Carrasco JA, Lloyd SA, Mellado-Sanchez G, Diaz-McNair J, Franco O, Buskirk AD, Nataro JP, Pasetti MF.

Infect Immun. 2015 Jan;83(1):161-72. doi: 10.1128/IAI.02443-14. Epub 2014 Oct 20.

10.

Effect of nanovaccine chemistry on humoral immune response kinetics and maturation.

Haughney SL, Ross KA, Boggiatto PM, Wannemuehler MJ, Narasimhan B.

Nanoscale. 2014 Nov 21;6(22):13770-8. doi: 10.1039/c4nr03724c.

PMID:
25285425
11.

Intranasal immunization with DNA vaccine coexpressing Der p 1 and ubiquitin in an allergic rhinitis mouse model.

Ou J, Shi W, Xu Y, Tao Z.

Ann Allergy Asthma Immunol. 2014 Dec;113(6):658-665.e1. doi: 10.1016/j.anai.2014.08.015. Epub 2014 Sep 17.

PMID:
25240330
12.

LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.

Sun W, Sanapala S, Henderson JC, Sam S, Olinzock J, Trent MS, Curtiss R 3rd.

Infect Immun. 2014 Oct;82(10):4390-404. doi: 10.1128/IAI.02173-14. Epub 2014 Aug 11.

13.

Efficacy of primate humoral passive transfer in a murine model of pneumonic plague is mouse strain-dependent.

Graham VA, Hatch GJ, Bewley KR, Steeds K, Lansley A, Bate SR, Funnell SG.

J Immunol Res. 2014;2014:807564. doi: 10.1155/2014/807564. Epub 2014 Jul 6.

14.

Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.

Dinc G, Pennington JM, Yolcu ES, Lawrenz MB, Shirwan H.

Vaccine. 2014 Sep 3;32(39):5035-40. doi: 10.1016/j.vaccine.2014.07.015. Epub 2014 Jul 18.

PMID:
25045812
15.

Multiple roles of Myd88 in the immune response to the plague F1-V vaccine and in protection against an aerosol challenge of Yersinia pestis CO92 in mice.

Dankmeyer JL, Fast RL, Cote CK, Worsham PL, Fritz D, Fisher D, Kern SJ, Merkel T, Kirschning CJ, Amemiya K.

J Immunol Res. 2014;2014:341820. doi: 10.1155/2014/341820. Epub 2014 Jun 4.

16.

[Evaluation of immunological efficiency induced by Campylobacter jejuni PEB1 DNA combined with PEB1 protein in mice].

Liu L, Lai W, Hu N, Zhang W, Chen T, Wang F, Gu R.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jun;30(6):576-80. Chinese.

PMID:
24909276
17.

Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine.

Su LK, Yu F, Li ZF, Zeng C, Xu QA, Fan MW.

Acta Pharmacol Sin. 2014 May;35(5):592-8. doi: 10.1038/aps.2013.184.

PMID:
24705100
18.

V-antigen homologs in pathogenic gram-negative bacteria.

Sawa T, Katoh H, Yasumoto H.

Microbiol Immunol. 2014 May;58(5):267-85. doi: 10.1111/1348-0421.12147. Review.

PMID:
24641673
19.

Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague.

Huang SS, Li IH, Hong PD, Yeh MK.

Int J Nanomedicine. 2014 Feb 7;9:813-22. doi: 10.2147/IJN.S56260. eCollection 2014.

20.

Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours.

Ross KA, Haughney SL, Petersen LK, Boggiatto P, Wannemuehler MJ, Narasimhan B.

Adv Healthc Mater. 2014 Jul;3(7):1071-7. doi: 10.1002/adhm.201300525. Epub 2014 Feb 12.

PMID:
24520022
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk